Quarterly report [Sections 13 or 15(d)]

REVENUES FROM CONTRACTS WITH CUSTOMERS (Tables)

v3.26.1
REVENUES FROM CONTRACTS WITH CUSTOMERS (Tables)
3 Months Ended
Mar. 31, 2026
REVENUES FROM CONTRACTS WITH CUSTOMERS  
Schedule of disaggregation of net revenues

​

​

​

​

​

​

​

​

​

​

Three-Month Periods Ended March 31, 

($ in thousands)

  ​ ​ ​

2026

  ​ ​ ​

2025

Emrosi®

​

$

6,252

​

$

2,070

Qbrexza®

​

​

5,028

​

​

5,161

Accutane®

​

 

3,314

​

 

3,655

Foam franchise products (Amzeeq® & Zilxi®)

​

​

1,050

​

​

1,526

Other / legacy

​

​

277

​

​

727

Total product revenues

​

$

15,921

​

$

13,139

Schedule of other revenue

​

​

​

​

​

​

​

​

​

​

Three-Month Periods Ended March 31, 

($ in thousands)

  ​ ​ ​

2026

  ​ ​ ​

2025

Royalties on sales of Amzeeq by Cutia

​

$

40

​

$

—

Total other revenue

​

$

40

​

$

—